The Valley Desk

NCT00481871 · Interventional trial

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

Overall registry status Completed

Phase 1 · Phase 2

Conditions B-cell Lymphoma, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma, Relapsed or Refractory Lymphoproliferative Malignancies, Waldenstrom's Macroglobulinemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov